CVE-2026-123051

Description

The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker with access to the executable could extract and reuse the credentials, potentially leading to unauthorized access to integration resources or manipulation of associated information, depending on the privileges granted and authentication controls in place.

Severity
LOW
CVSS v3
not scored
CVSS v4
1.2
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X · source cna
Exploit chance (EPSS)
not scored
CISA KEV
Not listed
Public exploit code
None public
Exploit references (NVD and CNA): 0
Metasploit modules: 0
Nuclei templates: 0

Weakness

CISA SSVC decision points

Exploitationnone
Automatableno
Technical impactpartial
Scored2026-11-17

Timeline

  1. 2026-11-17Published by the CNA14:26 UTC
  2. 2026-11-17Published in NVD15:17 UTC · 51 minutes after the CNA
  3. 2026-11-17CISA SSVC decision recordedsame day

The timeline shows what already happened. To be told when this CVE changes next, watch it from the API.

Affected products

Products listed as vulnerable. Upgrade to the version under "Fixed in", or a later one.

ProductVulnerable versionsFixed in
cipcarbone_srl farmasimplex_rev.exefrom 0 before 16.2.0fixed in 16.2.016.2.0

Products and versions as NVD and the vendor that published the CVE list them.

References

Get more CVE data from the API.

Free without a key or signup. Pro adds monitoring and higher limits: pricing.

Sources